Stocks in the health care sector are vulnerable to declines following the 2016 presidential election, according to S&P analyst Scott Kessler.
The company could divest non-core assets after Starboard Value revealed a 4.6% stake.
What to do with $40 billion? That is the question facing Allergan (AGN). One biotechnology stock which stands out as a potential target for Allergan is Applied Genetic Technologies (AGTC).
Stocks lose highs by mid-afternoon Wednesday as a selloff in crude resumes.